In the last trading session, 1.15 million Spero Therapeutics Inc (NASDAQ:SPRO) shares changed hands as the company’s beta touched 1.33. With the company’s per share price at $2.9 changed hands at -$0.04 or -1.36% during last session, the market valuation stood at $162.14M. SPRO’s last price was a discount, traded about -6.55% off its 52-week high of $3.09. The share price had its 52-week low at $0.51, which suggests the last value was 82.41% up since then. When we look at Spero Therapeutics Inc’s average trading volume, we note the 10-day average is 1.39 million shares, with the 3-month average coming to 4.16 million.
Analysts gave the Spero Therapeutics Inc (SPRO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 3.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SPRO as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Spero Therapeutics Inc (NASDAQ:SPRO) trade information
Instantly SPRO was in red as seen at the end of in last trading. With action -1.02%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 118.05%, with the 5-day performance at -1.02% in the red. However, in the 30-day time frame, Spero Therapeutics Inc (NASDAQ:SPRO) is 36.15% up. Looking at the short shares, we see there were 1.61 million shares sold at short interest cover period of 0.15 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 17.67%. The 2025 estimates are for Spero Therapeutics Inc earnings to increase by 9.45%, but the outlook for the next 5-year period is at 7.97% per year.
SPRO Dividends
Spero Therapeutics Inc is expected to release its next quarterly earnings report on 2025-May-13.
Spero Therapeutics Inc (NASDAQ:SPRO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 24.61% of Spero Therapeutics Inc shares while 23.25% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 30.83%. There are 23.25% institutions holding the Spero Therapeutics Inc stock share, with ANSON FUNDS MANAGEMENT LP the top institutional holder. As of 2024-06-30, the company held 7.007% of the shares, roughly 3.75 million SPRO shares worth $4.88 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 3.3079% or 1.77 million shares worth $2.3 million as of 2024-06-30.
